Clinical Trial Update: Phase IIa Clinical Trial of YN001 in Patients With Atherosclerotic Cardiovascular and Cerebrovascular Diseases and Erectile Dysfunction [Phase 2]

View source ↗

Summary

Phase IIa clinical trial update for YN001 targeting atherosclerotic cardiovascular disease and erectile dysfunction; the study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Erectile Dysfunction

Drugs mentioned

• YN001

Snippet

Sponsor: Beijing Inno Medicine Co., Ltd. | Conditions: Atherosclerotic Cardiovascular Disease (ASCVD), Erectile Dysfunction | Phase 2 | Status: NOT_YET_RECRUITING